The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
Saved in:
| Title: | The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. |
|---|---|
| Authors: | Aylon Y; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;, Gershoni A; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;, Rotkopf R; Bioinformatics Unit, Faculty of Biological Services, The Weizmann Institute of Science, Rehovot 76100, Israel;, Biton IE; Department of Veterinary Resources, Faculty of Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;, Porat Z; Flow Cytometry Unit, Biological Services Department, The Weizmann Institute of Science, Rehovot 76100, Israel;, Koh AP; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Sun X; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Lee Y; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Fiel MI; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Hoshida Y; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Friedman SL; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;, Johnson RL; Department of Biochemistry and Molecular Biology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Oren M; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel; |
| Source: | Genes & development [Genes Dev] 2016 Apr 01; Vol. 30 (7), pp. 786-97. Date of Electronic Publication: 2016 Mar 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 8711660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-5477 (Electronic) Linking ISSN: 08909369 NLM ISO Abbreviation: Genes Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27013235 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aylon+Y%22">Aylon Y</searchLink>; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;<br /><searchLink fieldCode="AU" term="%22Gershoni+A%22">Gershoni A</searchLink>; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;<br /><searchLink fieldCode="AU" term="%22Rotkopf+R%22">Rotkopf R</searchLink>; Bioinformatics Unit, Faculty of Biological Services, The Weizmann Institute of Science, Rehovot 76100, Israel;<br /><searchLink fieldCode="AU" term="%22Biton+IE%22">Biton IE</searchLink>; Department of Veterinary Resources, Faculty of Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;<br /><searchLink fieldCode="AU" term="%22Porat+Z%22">Porat Z</searchLink>; Flow Cytometry Unit, Biological Services Department, The Weizmann Institute of Science, Rehovot 76100, Israel;<br /><searchLink fieldCode="AU" term="%22Koh+AP%22">Koh AP</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Sun+X%22">Sun X</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Lee+Y%22">Lee Y</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Fiel+MI%22">Fiel MI</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Hoshida+Y%22">Hoshida Y</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Friedman+SL%22">Friedman SL</searchLink>; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA;<br /><searchLink fieldCode="AU" term="%22Johnson+RL%22">Johnson RL</searchLink>; Department of Biochemistry and Molecular Biology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.<br /><searchLink fieldCode="AU" term="%22Oren+M%22">Oren M</searchLink>; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel; – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711660%22">Genes & development</searchLink> [Genes Dev] 2016 Apr 01; Vol. 30 (7), pp. 786-97. <i>Date of Electronic Publication: </i>2016 Mar 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cold+Spring+Harbor+Laboratory+Press%22">Cold Spring Harbor Laboratory Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8711660 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-5477 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208909369%22">08909369 </searchLink><i>NLM ISO Abbreviation: </i>Genes Dev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27013235 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/gad.274167.115 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 786 Titles: – TitleFull: The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aylon Y – PersonEntity: Name: NameFull: Gershoni A – PersonEntity: Name: NameFull: Rotkopf R – PersonEntity: Name: NameFull: Biton IE – PersonEntity: Name: NameFull: Porat Z – PersonEntity: Name: NameFull: Koh AP – PersonEntity: Name: NameFull: Sun X – PersonEntity: Name: NameFull: Lee Y – PersonEntity: Name: NameFull: Fiel MI – PersonEntity: Name: NameFull: Hoshida Y – PersonEntity: Name: NameFull: Friedman SL – PersonEntity: Name: NameFull: Johnson RL – PersonEntity: Name: NameFull: Oren M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2016 Apr 01 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1549-5477 Numbering: – Type: volume Value: 30 – Type: issue Value: 7 Titles: – TitleFull: Genes & development Type: main |
| ResultId | 1 |